P-23 Clinical outcomes of encorafenib, binimetinib, and cetuximab for pretreated BRAF V600E-mutant metastatic colorectal cancer in the BEACON EAP follow-up study
Titel:
P-23 Clinical outcomes of encorafenib, binimetinib, and cetuximab for pretreated BRAF V600E-mutant metastatic colorectal cancer in the BEACON EAP follow-up study
Auteur:
Kato, T. Kotani, D. Takashima, A. Satoh, T. Masuishi, T. Komatsu, Y. Shiozawa, M. Esaki, T. Izawa, N. Takeuchi, S. Bando, H. Iwasa, S. Hasegawa, H. Yamaguchi, T. Taniguchi, H. Yamada, S. Yoshino, T.